Plasma fibrinogen levels in patients with benign and malignant ovarian tumors

Hefler-Frischmuth Katrin; Lafleur Judith; Hefler Lukas; Polterauer Stephan; Seebacher Veronika; Reinthaller Alexander; Grimm Christoph

首页> 外文期刊>Gynecologic Oncology: An International Journal >Plasma fibrinogen levels in patients with benign and malignant ovarian tumors

【24h】

Plasma fibrinogen levels in patients with benign and malignant ovarian tumors

机译：卵巢良恶性肿瘤患者血浆纤维蛋白原水平

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective. Plasma fibrinogen is a key acute phase protein and known to be elevated in ovarian cancer. We aimed to investigate the association between plasma fibrinogen and malignant and benign ovarian tumors.

机译：目的。血浆纤维蛋白原是一种关键的急性期蛋白，已知在卵巢癌中会升高。我们旨在研究血浆纤维蛋白原与恶性和卵巢良性肿瘤之间的关系。

著录项

来源
《Gynecologic Oncology: An International Journal》 |2015年第3期|共4页
作者
Hefler-Frischmuth Katrin; Lafleur Judith; Hefler Lukas; Polterauer Stephan; Seebacher Veronika; Reinthaller Alexander; Grimm Christoph;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
Benign ovarian tumors; Borderline ovarian tumors; Ovarian cancer; Differential diagnosis; Plasma fibrinogen;

机译：卵巢良性肿瘤;卵巢良性肿瘤;卵巢癌;鉴别诊断;血浆纤维蛋白原;

相似文献

外文文献
中文文献
专利

1. Plasma fibrinogen levels in patients with benign and malignant ovarian tumors [J] . Hefler-Frischmuth Katrin, Lafleur Judith, Hefler Lukas, Gynecologic Oncology: An International Journal . 2015,第3期

机译：卵巢良恶性肿瘤患者血浆纤维蛋白原水平
2. Differences in pteridine urinary levels in patients with malignant and benign ovarian tumors in comparison with healthy individuals [J] . Zvarik M., Martinicky D., Hunakova L., Journal of Photochemistry and Photobiology, B. Biology: Official Journal of the European Society for Photobiology . 2015,第Null期

机译：与健康个体相比，恶性和良性卵巢肿瘤患者蝶啶尿液水平的差异
3. Thrombin-antithrombin III and D-dimer plasma levels in patients with benign or malignant ovarian tumours. [J] . den-Ouden M, Ubachs JM, Stoot JE, Scandinavian journal of clinical and laboratory investigation. . 1998,第7期

机译：卵巢良性或恶性肿瘤患者的凝血酶-抗凝血酶III和D-二聚体血浆水平。
4. Laser polarimetry of bioliguids of patients with benign and malignant ovarian tumors [C] . A.P.Peresunko, Suhaiel Saidi ben Mouhamed, SPIE-The International Society for Optical Engineering, International Conference on Correlation Optics . 2004

机译：良性和恶性卵巢肿瘤患者的Bioliguids激光偏振偏振
5. Disparate Activation and Function of B Cells in Benign and Malignant Tumors of the Skin: Implications for Cancer Immunotherapy [D] . Podolsky, Michael Adam. 2017

机译：皮肤良性和恶性肿瘤中B细胞的不同激活和功能：对癌症免疫疗法的影响
6. The efficacy of sonographic morphology indexing and serum CA-125 for preoperative differentiation of malignant from benign ovarian tumors in patients after operation with ovarian tumors [O] . Hyo Young Jeoung, Han Song Choi, Yo Sup Lim, 2008

机译：超声形态学指标和血清CA-125对卵巢肿瘤术后恶性从卵巢良性肿瘤分化的疗效
7. Higher levels of interleukin-6 in cystic fluids from patients with malignant versus benign ovarian tumors correlate with decreased hemoglobin levels and increased platelet counts [O] . Ate G. J. Van Der Zee, Henk W. A. De Bruijn, Mindert Krans, 1995

机译：恶性患者与良性卵巢肿瘤患者的囊性液中囊性液中较高水平与血红蛋白水平降低和血小板计数增加

Plasma fibrinogen levels in patients with benign and malignant ovarian tumors

摘要

著录项

相似文献

相关主题

期刊订阅